Raymone Pajarillo

1.5k total citations
7 papers, 37 citations indexed

About

Raymone Pajarillo is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Raymone Pajarillo has authored 7 papers receiving a total of 37 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Raymone Pajarillo's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). Raymone Pajarillo is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). Raymone Pajarillo collaborates with scholars based in United States, Italy and South Korea. Raymone Pajarillo's co-authors include Marco Ruella, Puneeth Guruprasad, Patrizia Porazzi, Yong Gu Lee, Luca Paruzzo, Guido Ghilardi, Michael Wang, Steven Yang, Stefan K. Barta and Stephen J. Schuster and has published in prestigious journals such as Blood and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Raymone Pajarillo

6 papers receiving 37 citations

Peers

Raymone Pajarillo

ONCOL

MB

IMMUN

GENET

PRM

Kristen E. Rigolizzo United States

Kimberly B. Sprenger United States

Elizabeth Sirmans United States

Zhixiang Ren China

Ouiam Bakkacha United States

Irene del Molino del Barrio United Kingdom

Mignonette H. Macabali United States

Emily Giddings United States

Xiangji Wu China

Jeffrey Eastham United States

Kristen E. Rigolizzo United States

Raymone Pajarillo

16 ×0.8

ONCOL

12 ×0.6

MB

10 ×0.8

IMMUN

6 ×0.6

GENET

3 ×0.5

PRM

Citations per year, relative to Raymone Pajarillo Raymone Pajarillo (= 1×) peers Kristen E. Rigolizzo

Countries citing papers authored by Raymone Pajarillo

Since Specialization

Citations

This map shows the geographic impact of Raymone Pajarillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymone Pajarillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymone Pajarillo more than expected).

Fields of papers citing papers by Raymone Pajarillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymone Pajarillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymone Pajarillo. The network helps show where Raymone Pajarillo may publish in the future.

Co-authorship network of co-authors of Raymone Pajarillo

This figure shows the co-authorship network connecting the top 25 collaborators of Raymone Pajarillo. A scholar is included among the top collaborators of Raymone Pajarillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymone Pajarillo. Raymone Pajarillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Tang, Yan, Wei Liu, Omar Johnson, et al.. (2023). Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy. Blood. 143(2). 139–151. 9 indexed citations

2.

Lee, Yong Gu, Patrizia Porazzi, Luca Paruzzo, et al.. (2023). Apoptosis: a Janus bifrons in T-cell immunotherapy. Journal for ImmunoTherapy of Cancer. 11(4). e005967–e005967. 16 indexed citations

3.

Angelos, Mathew G., Wei Xie, Raymone Pajarillo, et al.. (2023). Fratricide-Resistant Anti-CD2 Chimeric Antigen Receptor T-Cells with Endogenous CD2 Knockout Are Highly Effective Against T-Cell Neoplasms. Blood. 142(Supplement 1). 885–885. 3 indexed citations

4.

Cohen, Ivan, Ki Hyun Kim, Scott A. Jenks, et al.. (2023). Precision Targeting of the Malignant Clone in Diffuse Large B Cell Lymphoma Using Chimeric Antigen Receptor T Cells Against the Clonotypic IGHV4-34 B Cell Receptor. Blood. 142(Supplement 1). 1020–1020. 1 indexed citations

5.

Ghilardi, Guido, Puneeth Guruprasad, Mathew G. Angelos, et al.. (2023). Disinhibition of T Cell Activation Via CD5 Knockout Is a Universal Strategy to Enhance Adoptive T Cell Immunotherapies. Blood. 142(Supplement 1). 102–102.

6.

Ghilardi, Guido, Patrizia Porazzi, Steven Yang, et al.. (2022). Clinical Development of Senza5TM CART5: a Novel Dual Population CD5 CRISPR-Cas9 Knocked out Anti-CD5 Chimeric Antigen Receptor T Cell Product for Relapsed and Refractory CD5+ Nodal T-Cell Lymphomas. Blood. 140(Supplement 1). 1604–1605. 7 indexed citations

7.

Ruella, Marco, Mireia Uribe‐Herranz, Silvia Beghi, et al.. (2021). Gut Microbiota Tuning Promotes Tumor-Associated Antigen Cross Presentation and Enhances CAR T Antitumor Effects. Blood. 138(Supplement 1). 163–163. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact